Login to Your Account

Professor Dr Hasniza Zaman Huri has been the founder Dean of Faculty of Pharmacy, Universiti Malaya since 1 September 2019, and a Professor of Clinical Pharmacy and Precision Medicine in the Department of Clinical Pharmacy and Pharmacy Practice. Professor Dr Hasniza and Diabetes are inseparable. She has ventured into translational Diabetes Research from bench to bedside for almost 20 years. Her research covers targeted therapy in endocrine diseases, clinical pharmacy, and precision health. Professor Dr Hasniza is also an expert in the clinical trial industry. She has published over 85 papers indexed in WOS in her area of expertise. She held various critical administrative posts, including the Manager of Clinical Investigation Centre (CIC) from 2012-2015 and was later appointed as the Director/Head of CIC (2015-2019). CIC, University Malaya Medical Centre is a world-class, reputable and multi-winning clinical trial centre. CIC has won many accolades at the international level, procured around 590 clinical trials, and worked with 300 pharmaceutical sponsors and CROs worldwide. Under her tenure, CIC is recognized as the first Prime Site for Quintiles (now IQVIA) in Asia, the first Strategic Alliance Site for Parexel Inc in Malaysia, Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) Site in Malaysia and the Best Clinical Trial Service Provider in Asia. She is also the Honorary Visiting Consultant at CIC and a member of the Drug Control Authority (DCA) Ministry of Health, Malaysia.